A comparison of features that were selected by XGBoost and analysis of features with statistically significant differences between IDH1 wildtype and mutants (Appendix A, Table A1) and between glioblastomas and non-glioblastomas (Appendix A, Table A2) shows the effectiveness of the automated feature selection. The gene discussed is IDH1; the disease is glioblastoma.